Onderzoeker
Wim Mulders
Affiliaties
- Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf17 sep 2007 → Heden - Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf31 dec 2014 → 16 apr 2015 - Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf28 feb 2014 → 16 jan 2015 - Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf31 okt 2013 → 7 mrt 2014 - Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf30 sep 2010 → 13 nov 2013
Publicaties
1 - 10 van 14
- Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid(2024)
Auteurs: Rupasinghe Arachchige Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, L Rigouts, W Mulders, Stefan Niemann, Matthias Merker, Claudio U. Koeser, Sari Cogneau, Shaheed Vally Omar, et al.
- Rifampicin resistance conferring mutations among Mycobacterium tuberculosis strains in Rwanda(2023)
Auteurs: Isabel Cuella Martin, Jean Claude Semuto Ngabonziza, Gabriela Torrea, Conor J. Meehan, W Mulders, Bertin Ushizimpumu, Louise De Weerdt, Jelle Keysers, Willem Bram de Rijk, Tom Decroo, et al.
Pagina's: 274-281 - Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678(2023)
Auteurs: Jihad Snobre, M C Villellas, Nele Coeck, W Mulders, Oren Tzfadia, Bouke de Jong, K Andries, L Rigouts
- Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century(2022)
Auteurs: Jean Claude Semuto Ngabonziza, L Rigouts, Gabriela Torrea, Tom Decroo, Eliane Kamanzi, Pauline Lempens, Aniceth Rucogoza, Yves Mucyo Habimana, Lies Laenen, Esdras Belamo Niyigena, et al.
- Finding the right balance between efficacy and tolerability for TB treatment: the search continues(2021)
Auteurs: A.K.J. Maug, M.A. Hossain, M Gumusboga, Tom Decroo, W Mulders, Sofie Braet, Jozefien Buyze, D A Jiménez, Céline Schurmans, Natacha Herssens, et al.
Pagina's: 84-86 - Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial(2021)
Auteurs: Mebrat Ejo Kitata, A Van Deun, A Nunn, SEO Meredith, S. Ahmed, D. Dalai, O. Tumenbayar, B. Tsogt, P. T. Dat, D. T. M. Ha, et al.
Pagina's: 839-845 - First-line tuberculosis treatment with double-dose rifampicin is well tolerated(2020)
Auteurs: A.K.J. Maug, M.A. Hossain, M Gumusboga, Tom Decroo, W Mulders, Sofie Braet, Jozefien Buyze, Diana Arango, Céline Schurmans, Natacha Herssens, et al.
Pagina's: 499-505 - Case report: dynamics of acquired fluoroquinolone resistance under standardized short-course treatment of multidrug-resistant tuberculosis(2020)
Auteurs: Jean Claude Semuto Ngabonziza, A Van Deun, Patrick Migambi, Niyigena Esdras Belamo, Dusabe Théogène, Yves Mucyo Habimana, Bertin Ushizimpumu, W Mulders, Tom Decroo, Dissou Affolabi, et al.
Pagina's: 1443-1446 - The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance(2020)
Auteurs: Armand Van Deun, Tom Decroo, Aung Kya Jai Maug, Mohamed Anwar Hossain, Murid Gumusboga, W Mulders, Nimer Ortuno-Gutierrez, Lutgarde Lynen, Bouke de Jong, Hans L. Rieder
- A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region(2020)
Auteurs: Jean Claude Semuto Ngabonziza, Chloe Loiseau, Michael Marceau, Agathe Jouet, Fabrizio Menardo, Oren Tzfadia, Rudy Antoine, Esdras Belamo Niyigena, W Mulders, K Fissette, et al.